Analytical Chemistry - Platform Modalities Leader

About this role

Responsibilities

• Platform Strategy, Ownership & Modernisation
• Provide
• end
• ‑
• to
• ‑
• end scientific ownership
• of existing analytical and purification platforms at Stevenage and supporting small molecule and next‑generation modalities, including divalent small molecules, WLPs, and oligonucleotides.
• Define and drive
• platform strategy and modernisation
• , ensuring analytical capabilities are scalable, automation‑ready, and aligned to future modality and pipeline needs.
• Critically evaluate existing platforms and workflows, setting direction for capability enhancement, technology adoption, and retirement where appropriate.
• Act as a key technical voice shaping
• capability roadmaps and investment priorities
• for analytical platforms.
• Senior Scientific & Technical Leadership
• Lead from the laboratory on the most complex and high‑impact analytical challenges, providing authoritative input into method development, troubleshooting, and platform design.
• Serve as a
• recognised internal expert
• in platform analytics, guiding experimental strategy, data interpretation, and risk‑based decision‑making.
• Set expectations for robustness, reproducibility, and data quality, influencing best practice across analytical workflows and teams.
• High‑Throughput & Workflow Integration
• Drive the strategic integration of
• high‑throughput purification and analytical workflows
• to enable efficient, end‑to‑end support of emerging modality pipelines.
• Provide scientific leadership at the interface of analysis, bespoke purification, informatics, and automation to ensure platform coherence and long‑term sustainability.
• Influence platform design choices to maximise throughput, data quality, and downstream usability.
• Enterprise Collaboration & Influence
• Operate as a
• senior matrix leader
• , partnering with Discovery Chemistry, Modality teams, Informatics, Automation, and external collaborators to align platform capabilities with business priorities.
• Communicate analytical platform strategy, capability, limitations, and opportunity clearly to senior scientific and functional stakeholders.
• Translate complex technical capability into clear value propositions and guidance for project and portfolio‑level decision‑making.
• Governance, Quality & Continuous Improvement
• Ensure analytical platforms meet high standards of
• quality, safety, and compliance
• , consistent with organisational and regulatory expectations.
• Contribute to governance forums, providing expert input into prioritisation, risk assessment, and investment decisions related to analytical platforms.
• Drive continuous improvement using
• data‑led insight
• , performance metrics, and lessons learned across programmes and modalities.
• Basic Qualifications & Skills
• BSc or equivalent in Chemistry, Analytical Chemistry, Pharmaceutical Sciences, or a related discipline, with at least 10 years of postgraduate experience in analytical chemistry.
• Deep, demonstrable expertise in analytical platforms and associated analytical techniques relevant to modern drug modalities (e.g. LC‑MS, HRMS, advanced separations, high‑throughput and automated analysis).
• Proven experience
• modernising or transforming analytical platforms
• to support new modalities, including at least one of bifunctional molecules, oligonucleotides, or WLPs for ADCs.
• Strong scientific judgement with the credibility to lead complex decisions from the laboratory through to platform strategy.
• Experience influencing and shaping high‑throughput and automated analytical or purification solutions.
• Extensive experience of
• matrix leadership
• , delivering outcomes through influence across multiple functions and reporting lines.
• Strong team player with excellent communication skills and the ability to engage, challenge, and influence senior scientific and functional leaders as evidenced by publication and/or external presentations.
• Preferred Qualifications & Skills
• PhD in Analytical Chemistry, Chemistry, or a related discipline, or MSc with significant and directly relevant experience.
• Hands‑on experience supporting complex or emerging modalities such as divalent molecules, WLPs, and oligonucleotides.
• Experience shaping
• enterprise‑level platform strategy
• , long‑term capability roadmaps, and/or capital investment proposals.
• Track record of delivering
• step‑change improvements
• through cross‑functional partnership spanning science, informatics, and technology.
• This role will be based 100% on site.
• How to apply
• If this role speaks to you, please apply now. In your application, use the cover letter or CV to describe how your experience meets the requirements. We encourage candidates from all backgrounds to apply.
• Application close date - 11th June 2026
• 




• Why GSK?
• Uniting science, technology and talent to get ahead of disease together.
• GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
• People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.
• GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.
• We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
• Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us at
• UKRecruitment.Adjustments@gsk.com
• where you can also request a call.
• Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a  Recruitment FAQ guide. Click the
• link
• where you will find answers to multiple questions we receive
• Important notice to Employment businesses/ Agencies
• GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
• Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at
• https://openpaymentsdata.cms.gov/